GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective Study

Obes Surg. 2017 Mar;27(3):703-708. doi: 10.1007/s11695-016-2345-3.

Abstract

Background: Changes in satiety regulation are known to play a pivotal role in the weight loss effects of Roux-en-Y gastric bypass (RYGB) and the mechanisms by which these changes occur are not entirely known. There are previous reports of the influence of GLP-1 to cause enhancement of satiation, but in regard to GLP-2, it remains unclear. This study aimed to determine whether there is a correlation between the levels of GLP-1 and GLP-2 and satiety regulation following RYGB.

Materials and methods: An exploratory prospective cohort study was made which enrolled 11 individuals who underwent RYGB and were followed-up for 12 months. GLP-1 and GLP-2 levels were determined before and after surgery and correlated with visual analogue scale scores for satiety.

Results: GLP-2 AUC after standard meal tolerance test (MTT) was significantly higher following surgery (945.3 ± 449.1 versus 1787.9 ± 602.7; p = 0.0037). Postoperatively, GLP-1 AUC presented a significant negative correlation with the mean score obtained in the first question of the visual analogue scale ("how hungry do you feel?") (p = 0.008); GLP-2 AUC presented a significant positive correlation with the mean score of the third ("how full do you feel?") question, and a significant positive correlation with the mean score achieved in the fourth question ("how much do you think you can eat?"), (p = 0.005 and p = 0.042, respectively).

Conclusion: GLP-1 and GLP-2 were significantly correlated with satiety assessment within this sample. Further research is necessary to confirm these findings.

Keywords: Bariatric surgery; Gastric bypass; Glucagon-like peptides; Obesity; Satiety response.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Appetite Regulation*
  • Female
  • Gastric Bypass / methods*
  • Glucagon-Like Peptide 1 / blood*
  • Glucagon-Like Peptide 2 / blood*
  • Humans
  • Hunger / physiology
  • Male
  • Middle Aged
  • Obesity, Morbid / blood
  • Obesity, Morbid / metabolism
  • Obesity, Morbid / surgery*
  • Postoperative Period
  • Prospective Studies
  • Satiation / physiology*
  • Weight Loss / physiology
  • Young Adult

Substances

  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide 1